-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation